Enphasys have now been granted an European patent for our in vitro intestinal drug disposition device. The device have shown to accurately predict the in vivo performance of lipid-based formulations in several different species, due to presence of an absorption chamber. We are looking forward to make this promising technology available for formulators around the world.
Further reading can be found here:
https://www.prv.se/sv/foretagare/foretagare-berattar/enphasys
https://www.sciencedirect.com/science/article/pii/S016836591930241X
https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b00811
